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ABSTRACT
Background. Dysfunction of the liver after transplantation may be related to the graft
size and ischemia/reperfusion (I/R) injury. N-Acetylcysteine (NAC) exerts beneficial
effects on livers undergoing ischemia reperfusion. We sought to evaluate NAC modulation
on reduced livers associated with I/R injury.
Methods. Male C57BL/6 mice of 8 weeks of age were divided into groups: 50%
hepatectomy (G-Hep); NAC (G-Hep  NAC [150 mg/kg]) via vena cava 15 minutes
before hepatectomy; ischemia (G-Hep  IR); NAC with hepatectomy (G-IR  Hep 
Nac); and IR using 30 minutes selective hepatic occlusion and reperfusion for 24 hours.
After 24 hours, the remaining liver was removed, for staining with hematoxylin and eosin
or labeling by proliferating cell nuclear antigen. Blood was collected for biochemical
evaluations. Significance was considered for P  .05.
Results. Aspartate aminotransferase was high in all studied groups reflecting the hepatec-
tomy and intervention. injuries. However, when assessing alanine aminotransferase, which
depicts liver function, induction of IR promoted a greater increase than hepatectomy (P 
.0003). NAC decreased ALT activity in all groups, even in association with I/R (P  .05),
reflecting a modulation of the injury. Necrosis resulting from IR was mitigated by NAC. The
experimental model of 50% reduced live promoted regeneration of the hepatic remnant, which
was accentuated by NAC, according to the total number of hepatocytes and PCNA values.
Conclusion. NAC preserved the remnant liver in mice and stimulates regeneration even
after IR injury.
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tLIVER transplantation is a therapeutic resource forpatients with irreversible liver failure; however, the
shortage of organ donors requires innovative approaches to
meet the demand. The broadening of clinical criteria con-
cerning the suitability of donors, and the division of the liver
to supply 2 recipients are alternatives to increase organ
availability. Hepatectomy after division of the organ1 in-
uces a regeneration process in the lurer parenchyma.1–7
The events resulting from hepatectomy are sequential,
occuring over a week after the resection.8 Moreover, the
educed amount of liver tissue increases portal blood flow.
hus, graft dysfunction after transplantation occurs fre-
uently its intensity depends upon a combination of nega-
ive factors in addition to the ischemia and reperfusion
I/R) lesions already imposed on the transplanted organ.
Previous studies have sought to mitigate the damage caused
y I/R using preconditioning protective strategies. Pharmaco-
ogic preconditioning has employed drugs to modulate I/R
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Transplantation Proceedings, 44, 2321–2325 (2012)njury, among which is N-acetylcysteine (NAC). By increasing
epatic glutathione, which is a substrate for inactivation of
oreign substances; by scavenger actions on oxygen reactive
pecies; or by improving microcirculation,9–11 NAC, commer-
ially available low-molecular-weight thiol.12,13 The therapeu-
ic use of NAC has been established for acetaminophen
oxicity hepatitis, wherein it protects the liver by increasing
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2322 SILVA, CARBONEL, TAHA ET ALhepatic glutathione, which serves as a substrate to inactivate or
combined with foreign substances.12,14–18
NAC, an amino acid derived from cysteine, has protective
pulmonary effects,16,19 as well as antioxidant and mucolytic ac-
ions acting to remove EROs.17–19 Its use in clinical practice also
occurs in situations of hemodynamic instability to protect the
liver, lung, heart, and kidney tissues, which are compromised by
ischemia followed by reperfusion. This amino acid is both an
analogue and a precursor of intracellular glutathione synthe-
sis.17,20 It has protective effects on normothermic I/R liver lesions
when injected before induction of ischemia, with maintained
aerobic conditions.8 Additionally, it acts as a direct antioxidant, by
eacting with hydroxyl radicals, by improving blood flow in the
icrocirculation,18,19,21 by inhibiting production of reactive nitro-
gen species,19 and by the synthesis of proinflammatory cytokines.
The protective effect of NAC has already been reported in
xperimental models of fulminant hepatitis.14,15 After a study
f selective hepatic I/R in mice,20 the authors observed NAC
o inhibit activation of the expression of Toll-like receptors 2
nd 4 in the liver, probably owing to the inhibition of nuclear
ranslocation of nuclear factor-kappa B, which is activated by
ROs. They also showed that NAC promotes morphologic
nd functional preservation of liver tissue during the ischemic
hase,18,20 decreasing the degree of hepatic congestion after
reperfusion. due to improved blood flow in microcirculation22
probably owing to antioxidant effects, thereby promoting
greater bioavailability of nitric oxide (NO), resulting in vaso-
dilation.23 NAC has also been observed to reduce the occur-
rence of necrosis, apoptosis, and microvesicular steatosis.18
Our laboratory has been investigating precinditioning with
NAC12,18 to mitigate I/R. We observed preservation of liver
orphology in the ischemia phase and after reperfusion with
ecreased vascular congestion as well as necrosis, apoptosis,
nd microvesicular steatosis thereafter. Thus, considering that
iver dysfunction after transplantation may relate to the size of
he graft and the I/R lesions, and that NAC exerts beneficial
ffects on the hepatic parenchyma, we evaluated the modula-
ion exerted by NAC on a reduced size liver organ with or
ithout combined I/R lesions in mice.
METHODS
This study, approved by the Research Ethics Committee (0082/08),
used 21 C57BL/6 male mice of approximately 8 weeks old that
weighed 25–30 30 g obtained from the Institute of Pharmacy,
UNIFESP. All animals were kept in individual cages in a temper-
ature-controlled room with light/dark cycles of 12 hours.
The animals were fasted rom solids for 4 hours before the operative
procedure. After receiving atropine (0.044 g/kg) as pretreatment mice
were anesthetized with katamine and xylazine by intramuscular injec-
tion (70 and 10 mg/kg of body weight, respectively). After abdominal
trichotomy and antisepsis with 70% alcohol, we hydrated the animal
with saline solution (0.8 mL/10 g body weight), injected subcutane-
ously into the lateral region of the abdomen. The animals were kept in
heating pad at 38°C throughout the procedure.
The animals were randomized into 4 groups after a median
laparotomy from the xiphoid toward the tail: Hepatectomy
(GHep); hepatectomy  NAC (GHepNac); hepatectomy associ-ated with I/R (GHeplR): and hepatectomy associated with I/R and
NAC (GHepNACIR).
We slowly injected NAC (150 mg/kg) NAC Protocol into the
caudal vena cava at a dose 15 minutes before hepatectomy or
ischemia. To perform selective hepatic I/R, animals underwent
occlusion of the hepatic pedicle above the level of the right lateral
branch segments, caudate lobe, and papillary process with a
microsurgical vascular clamp for 30 minutes followed by 24 hours
of reperfusion. After identification and isolation of the branches of
the right lateral lobes, caudate, square, median, and papillary
processes of the liver, we resected 50% of the liver parenchyma as
adapted from the model described by Yadav et al.24
After the procedure the abdomen was closed in 2 layers using 6-0
wire. Under anesthesia. Twenty-four hours, later, blood samples
were collected to assess aminotransferase levels with the remaining
liver used for morphologic and morphometric analysis. Liver
samples fixed in formalin 10% were kept in closed containers for 24
Fig 1. Values of the activity of asparate aminotransferase (AST)
and alanine aminotransferase (ALT), expressed in U/L. Hep,
hepatectomy; IR, ischemia/reperfusion; NAC, N-acetylcysteine.
ANOVA *P  .0003; HepNAC, HepIRNAC  HepIR).
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EFFECT OF N-ACETYLCYSTEINE 2323hours, dehydrated with alcohol solutions. After embedding in
paraffin, the samples cut at 3 microns were stained with hema-
toxyulin and eosin (HE). Thereafter samples were mounted on
silanized slides for immunohistochemistry for proliferating cell
nuclear antigen (PCNA) labeling.
The data were evaluated by analysis of variance with differences
examined by Tukey’s multiple comparison test. P  .05 was
considered significant.
RESULTS
Aminotransferase activity was increased among all studied
groups, showing the hepatectomy and I/R injuries ALT
activity, which reflects hepatic function showed a greater
increase when I/R was superimposed on isolated hepatec-
tomy, but without significance (P  .05). NAC induced a
decrease in alanine aminotransferase (ALT), including
Fig 2. Photomicrography showing morphological aspects of t
without vascular congestion and rare picnotic nucleus (stain, HE
HB), with 1 nucleolus (NC) and cytoplasmic fatty vesicles (V
bsence of vascular congestion and many nuclei (N) rich in heter
epatocytes (HB) with intense amount of fatty vesicles (VCL; sta
ndicating cellular death (stain, HE; original magnification  100
agnification,  100). (2B) Area of necrosis (NCR). (C3B) Area wi
esicles (VCL; stain, HE; original magnification,  400). (4A) Group
(4B) Large amount of fatty vesicle (VCL), binucleate hepatocytes (HB; shose that occurred in association with ischemia/reperfu-
ion after hepatectomy (P  .0003), showing downregula-
ion of the injury (Fig 1).
Morphologic and Morphometric Evaluation
Among the hepatectomy group (Hep), the liver parenchyma
showed maintenance of the hepatic cords, central veins, and
sinusoids. There were abnormal hyaline areas within the
majority of hepatocytes, probably owing to fat accumulation.
The hepatocytes were binucleate, with nuclei rich in euchro-
matin with1 nucleoli. (Fig 2.1A and B). NAC did not modify
the parenchyma architecture, but enhanced the steatosis
(HepNAC Fig 2.3A and B).
Among hepatectomized animals with added I/R
(HepIR), there were areas of heterochromatic, small nu-
er in all studied groups. (1A) Group Hep. Hepatic parenchyma
inal magnification,  100). (1B) Various binucleate hepatocytes
stain HE; original magnification,  400). (3A) Group HepNAC
omatin (stain, HE; original magnification,  100). (3B) Binucleate
E; original magnification,  400). (2A) Many picnotic nuclei (N),
2) Necrosis (NCR) of the hepatic parenchyma (stain; HE; original
necrosis with pinotic nuclei (N), indicating cellular death and fatty
IRNAC Intense steatosis (stain, HE; original magnification,  100).he liv
; orig
CL;
ochr
in, H
). (C
thout
Heptain, HE; original magnification,  400).
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2324 SILVA, CARBONEL, TAHA ET ALclei, indicating low metabolic activity, as well as the pres-
ence of inflammatory infiltrates and areas containing hepa-
tocytes with eosinophilic cytoplasm and pycknotic nuclei,
indicating cellular degeneration and/or necrosis (Fig 2.2A
and B). Addition of NAC (HeplRNAC), lead to lack of
necrotic areas and inflammatory infiltrates, although in-
tense fatty infiltrates, small nuclei, and nucleoli were evi-
dent (Fig 2.4A and B). Center veins diameters were similar
among all groups, showing that there was no difference
related to vascular congestion (Hep  70 m; HelpR  66
m; HepNAC  64 m; HeplRNAC  52 m; P  .05).
The proliferative activity in the remnant liver after 50%
hepatectomy, was increased with NAC, even when associ-
ated with I/R, as observed by the total number of hepato-
cytes (Fig 3). However, the number of binucleate hepato-
Fig 3. Total number of hepatocytes. Hep, hepatectomy; IPC,
ischemic preconditioning; IR, ischemia/reperfusion; NAC,
N-acetylcysteine. ANOVA: Hep, HepIR  HepNAC, HepIRNAC
(P  .0001). Number of binucleate hepatocytes was similar in allroups (P  .05).cytes did not show a significant difference among the
studied groups (P  .05).
Proliferative activity was enhanced using NAC associated
with hepatectomy, as observed by the percentage of PCNA-
labeled hepatocytes in all groups: Hep  4.6%; HeplR 
5.2%; HepNAC  8.3%; HepIR  6.2% (P  .05, com-
paring the HepNAC group with the others).
DISCUSSION
The complex mechanisms of liver injuries in clinical situa-
tions have lead to the development of protective strategies.
As an experimental model, the rat has been partially
replaced by mice which include genetically modified strains
facilitating the study of mechanisms of injury and modula-
tion.25 Moreover, this mammal has liver metabolism com-
parable to humans, despite the anatomic peculiarities,24
such as a multilobed liver.
In our study, NAC showed protective effects on hepatic
enzymes with decreased ALT activity after hepatectomy
even associated with an I/R injury, which was much higher
than the posthepatecomy alone value. In a study assessing
ischemia and reperfusion in mice, Yadav et al24 observed a
eak of transaminases after 6 hours with a fall at 24 hours.
n a clinical study, Koneru et al22 reported that the value
hanges did not show significance.
The extensive liver injury caused by I/R depends on the
recondition of the liver and the duration of the ischemic
nsult. It can lead to liver or multiple organ failure.26,27 The
ncreased morbidity and mortality occurs in the state of
noxia or ischemic liver injury as in extensive resections and
ransplantation, or as a result of conditions that decrease
lood flow to the liver, resulting in systemic hypoxia and
oor perfusion.26,27 Ischemia causes a proinflammatory
state increasing tissue vulnerability during reperfusion lead-
ing to necrosis and apoptosis.28
Partial hepatectomy produces an essentially hyperplastic
response with regeneration of cells and tissues over 3–14
days, resulting in restoration of glandular volume. The end
result is influenced by the mechanisms controlling growth
and cell proliferation. Even after hepatectomy the remnant
liver still in the regenerative phase, can maintain liver
functions necessary to sustain homeostasis at normal lev-
els.29
Morphologic evaluation reveald necrosis in the remnant
liver when subjected to I/R which was abolished with NAC
treatment. These data in mice subjected to ischemic pre-
conditioning corroborated the findings of decreased hepatic
necrosis12,14 and cell death by apoptosis.12,30 NAC has been
reported to decrease necrosis in livers of normal rats
subjected to I/R12; however, scant data are available to
address I/R associated with hepatectomy.
By morphometric analysis, we sought to evaluate the
presence of stasis in the central lobular vein. Neither liver
resection nor I/R promoted venous stasis in our model,
probably owing to selective occlusion and prolonged reper-
fusion, allowing the repair of acute injury. Medeiros et al9
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EFFECT OF N-ACETYLCYSTEINE 2325reported the maintenance of liver tissue architecture with
the central lobular vein free of dilatation and unchanged
sinusoids in the presence of NAC.
The evaluation of the total amount of hepatocytes,
reflecting liver regeneration, showed that NAC stimulated
hepatocyte hyperplasia in hepatectomized animals. The
number of binucleate hepatocytes was increased in I/R
when compared with hepatectomized animals, but without
a significant difference. Tanou et al31 studied posthepatec-
omy regeneration in mice, noting that after 24 hours there
as increased regeneration with augmentation of cells
ositive for PCNA, corroborating our findings. However,
hen examining the hepatic regeneration state of binucle-
te hepatocytes this evidence is lost, probably owing to the
ccurrence of the division of hepatocytes, reflected by the
otal number of hepatocytes already advanced at the time of
valuation.
In conclusion, our experimental model of a 50% reduced
iver showed NAC, promote to regeneration of the remnant
s evidenced by the total number of hepatocytes and
CNA, as well as its function, even associated with I/R
njury.
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